These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28786969)

  • 1. Efficacy of carbocisteine in the treatment of chronic obstructive pulmonary disease and impact on the quality of life.
    Alibašić E; Skopljak A; Čengić A; Krstović G; Trifunović N; Čatić T; Kapo B; Mehić M; Hadžimuratović A
    Med Glas (Zenica); 2017 Aug; 14(2):182-188. PubMed ID: 28786969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study.
    Esposito A; Valentino MR; Bruzzese D; Bocchino M; Ponticiello A; Stanziola A; Sanduzzi A
    Pulm Pharmacol Ther; 2016 Apr; 37():85-8. PubMed ID: 26970503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease.
    Tatsumi K; Fukuchi Y;
    J Am Geriatr Soc; 2007 Nov; 55(11):1884-6. PubMed ID: 17979906
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study.
    Zheng JP; Kang J; Huang SG; Chen P; Yao WZ; Yang L; Bai CX; Wang CZ; Wang C; Chen BY; Shi Y; Liu CT; Chen P; Li Q; Wang ZS; Huang YJ; Luo ZY; Chen FP; Yuan JZ; Yuan BT; Qian HP; Zhi RC; Zhong NS
    Lancet; 2008 Jun; 371(9629):2013-8. PubMed ID: 18555912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis.
    Zeng Z; Yang D; Huang X; Xiao Z
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2277-2283. PubMed ID: 28814855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbocisteine for acute exacerbations of COPD.
    Waller P; Suissa S
    Lancet; 2008 Nov; 372(9650):1630; author reply 1631-2. PubMed ID: 18994655
    [No Abstract]   [Full Text] [Related]  

  • 7. Carbocisteine for acute exacerbations of COPD.
    Mohapatra PR; Aggarwal D
    Lancet; 2008 Nov; 372(9650):1630-1; author reply 1631-2. PubMed ID: 18994656
    [No Abstract]   [Full Text] [Related]  

  • 8. The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease.
    Hooper C; Calvert J
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):659-69. PubMed ID: 19281081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effective evaluation on symptoms and quality of life of chronic obstructive pulmonary disease patients treated by comprehensive therapy based on traditional Chinese medicine patterns.
    Li JS; Li SY; Xie Y; Yu XQ; Wang MH; Sun ZK; Ma LJ; Jia XH; Zhang HL; Xu JP; Hou CX
    Complement Ther Med; 2013 Dec; 21(6):595-602. PubMed ID: 24280466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of carbocisteine on type A seasonal influenza virus infection in human airway epithelial cells.
    Yamaya M; Nishimura H; Shinya K; Hatachi Y; Sasaki T; Yasuda H; Yoshida M; Asada M; Fujino N; Suzuki T; Deng X; Kubo H; Nagatomi R
    Am J Physiol Lung Cell Mol Physiol; 2010 Aug; 299(2):L160-8. PubMed ID: 20543005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study.
    Nonato NL; Nascimento OA; Padilla RP; de Oca MM; Tálamo C; Valdivia G; Lisboa C; López MV; Celli B; Menezes AM; Jardim JR
    Chron Respir Dis; 2015 Aug; 12(3):264-73. PubMed ID: 26041119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities of daily living.
    Shioya T; Satake M; Sato K; Sano MA; Sugawara K; Takahashi H; Honma M
    Arzneimittelforschung; 2008; 58(1):24-8. PubMed ID: 18368947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
    Fernández-Villar A; López-Campos JL; Represas Represas C; Marín Barrera L; Leiro Fernández V; López Ramírez C; Casamor R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():961-7. PubMed ID: 26028969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mucoactive drug carbocisteine ameliorates steroid resistance in rat COPD model.
    Song Y; Yu P; Lu JJ; Lu HZ; Zhu L; Yu ZH; Chen HZ; Cui YY
    Pulm Pharmacol Ther; 2016 Aug; 39():38-47. PubMed ID: 27328977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dyspnea and clinical variables on the quality of life and functional capacity in patients with chronic obstructive pulmonary disease and congestive heart failure.
    Karapolat H; Eyigor S; Atasever A; Zoghi M; Nalbantgil S; Durmaz B
    Chin Med J (Engl); 2008 Apr; 121(7):592-6. PubMed ID: 18466677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
    Franciosi LG; Diamant Z; Banner KH; Zuiker R; Morelli N; Kamerling IM; de Kam ML; Burggraaf J; Cohen AF; Cazzola M; Calzetta L; Singh D; Spina D; Walker MJ; Page CP
    Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What predicts change in pulmonary function and quality of life in asthma or COPD?
    Hesselink AE; van der Windt DA; Penninx BW; Wijnhoven HA; Twisk JW; Bouter LM; van Eijk JT
    J Asthma; 2006 Sep; 43(7):513-9. PubMed ID: 16939991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.